Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
Leukemia, B-Cell
×
obinutuzumab
×
Clear all
Filters
3
NCT04515238
2025-06-10
CLL2-BZAG
German CLL Study Group
Phase 2
Active not recruiting
42 enrolled
NCT03787264
2024-12-30
CLL2-BAAG
German CLL Study Group
Phase 2
Completed
46 enrolled